The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 ...
The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.
Some patients with diabetes may be missing critical safety alerts on their phones, the FDA warned on Wednesday.
Dr. Medha N. Munshi, geriatrician and endocrinologist at BIDMC leads research on improving care for older adults with diabetes using digital technologies.
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...
The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical safety alerts.
Patients who use smartphone apps to manage their diabetes could face serious health problems if they miss notifications ...